Factors affecting development of Clostridium difficile infection in hospitalized pediatric patients in the country

Iuri Migriauli1, Vakhtang Meunargia2, Ivane Chkhaidze3,4

  • 1AIETI Medical School, David Tvildiani Medical University, Tbilisi, Georgia. iurimigriauli@dtmu.edu.ge.

BMC Research Notes
|June 27, 2018
PubMed

Insights

Clostridium difficile infections affect 10.5% of hospitalized children in Georgia. Antibiotic exposure, particularly cephalosporins, significantly increases the risk of C. difficile infection in this vulnerable population.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Microbiology
  • Healthcare Epidemiology

Background:

  • Clostridium difficile is a significant cause of healthcare-associated infections.
  • Pediatric populations are susceptible to C. difficile infections (CDI).
  • Understanding CDI prevalence and risk factors in pediatric settings is crucial for effective management.

Purpose of the Study:

  • To determine the occurrence of Clostridium difficile in hospitalized pediatric patients in Georgia.
  • To identify risk factors associated with the development of C. difficile infection.
  • To evaluate real-time PCR diagnostic systems for pathogen identification.

Main Methods:

  • A cross-sectional study involving 220 hospitalized children (<18 years) with gastroenteritis symptoms.
  • Stool specimens were analyzed using enzyme immune assay and polymerase chain reaction.
  • Real-time PCR systems were piloted for rapid C. difficile and other pathogen detection.

Main Results:

  • Overall, 10.5% of the pediatric patients tested positive for C. difficile.
  • Antibiotic exposure within two months prior to diarrhea onset was a significant risk factor.
  • Cephalosporins, penicillins, carbapenems, and macrolides were associated with increased CDI risk.

Conclusions:

  • Clostridium difficile is an important cause of healthcare-associated diarrhea in Georgia's pediatric patients.
  • Antibiotic use is a key modifiable risk factor for CDI in hospitalized children.
  • Rapid diagnostic methods like real-time PCR are valuable for timely C. difficile detection.
Abstract

Related Concept Videos

Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K